Thyrotoxic Periodic Paralysis and its Management: A Case Report | Chapter 3 | Medical Science: Recent Advances and Applications Vol. 1

Thyrotoxic periodic paralysis (TPP) is characterized by the abrupt onset of hypokalemia and paralysis. This condition primarily affects the lower extremities but may affect both upper and lower extremities and is secondary to thyrotoxicosis. It is most commonly seen in Asian men, and it has been increasingly reported in the USA due to the rise in the immigrant population. Hypokalemia in TPP results from an intracellular shift of potassium induced by the thyroid hormone sensitization of Na+/ K+ ATPase rather than depletion of total body potassium. In this case report, A 31-year-old Hispanic male arrived at the Emergency Room by Emergency Medical Service with complaints of lower and upper Extremities weakness. The patient was diagnosed with TPP due to the patient’s past medical history and latest symptoms. There are other differential diagnoses that could present with extremity paralysis, such as Guillain-Barré syndrome, meningitis, Stroke, medication side effects, or even malignancy. But TPP is one of the diagnoses often missed due to its low occurrence and also because of unawareness about this disorder. Therefore, increased awareness among physicians regarding this condition would also result in early diagnosis, appropriate management, and prevention of thyrotoxic periodic paralysis.

 

Author (s) Details

 

Nimat Alam
Department of Family and Community Medicine, Texas Tech University Health Science Center, USA.

 

Linda Esteban
Department of Family and Community Medicine, Texas Tech University Health Science Center, USA.

 

Enrique Tobias
Department of Family and Community Medicine, Texas Tech University Health Science Center, USA.

 

Jenet George
Department of Family and Community Medicine, Texas Tech University Health Science Center, USA.

 

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v1/4856

Acute Flaccid Paralysis and Neurogenic Respiratory Failure Associated with Enterovirus D68 | Chapter 10 | Current Progress in Medicine and Medical Research Vol. 2

 Both severe flaccid paralysis (AFP) and neurogenic respiring failure exceptionally occur before. At the end of 2018, some youth with two together symptoms were admitted to our ward and enterovirus D68 (EV-D68) was detected in the seat sample of one case. In this study, we aimed to evaluate two typical cases of the children to devote effort to something EV-D68.The two cases in this study displayed AFP and neurogenic respiratory failure precipitated by severe instigative injury mainly to the beginning horn cells of the sleep-inducing or numbing drug cord. These environments are different from ADEM, which primarily involves the silvery matter of the nervous system. Therefore, the diagnosis of ADEM was excluded. Two children permitted to our hospital presented accompanying symptoms and imaging results various from those of acute scattered encephalomyelitis and hand, foot, and backtalk disease. Their main manifestations were AFP and neurogenic respiratory failure. The prior horn containers of the spinal cord were generally damaged by severe instigative inflammation, in accordance with magnetic resonance image. Pathogens such as microorganisms, TB, cryptococcus, herpes virus, and coxsackie bug were not found in the blood or using one's brain fluid samples that were taken. The two cases' nasopharyngeal, ancestry, and cerebrospinal fluid samples weren't initially examined for EV-D68.  About 2 mo later, EV-D68 was discovered in the stool sample of individual of the cases. The symptom of AFP was caused by harm to the anterior alarm cells at levels C5-L5 of the spinal rope, while neurogenic respiratory failure was at levels C3-C5.EV-D68 possibly causes AFP and neurogenic respiratory defeat in some children. We bear pay attention to the early discovery and diagnosis of EV-D68 and what’s more important search out develop antivirus drugs and vaccines.

Author(s) Details:

Yv Zhang,

Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

Sheng-Yuan Wang,

Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

Da-Zhi Guo,

Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

Shu-Yi Pan,

Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

Yan Lv,

Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, Beijing 100048, China.

Please see the link here: https://stm.bookpi.org/CPMMR-V2/article/view/11290